Prospective international observational cohort non-comparative study describing the safety and effectiveness of ZALTRAPĀ® administered in combination with FOLFIRI for the treatment of patients with metastatic colorectal cancer in current clinical practice: A Post-Authorisation Safety Study (PASS) (OZONE)

03/10/2013
19/06/2024
EU PAS number:
EUPAS4836
Study
Finalised
Documents
Study protocol
Initial protocol
English (480.06 KB - PDF) View document
Updated protocol
English (623.21 KB - PDF) View document
Study results
Study results
English (1.2 MB - PDF) View document
Study report
Other information